FRI0094 Outcomes of two years of remission steered treatment in early arthritis patients

FRI0094 Outcomes of two years of remission steered treatment in early arthritis patients

Objectives To evaluate the 2 year clinical outcomes of remission steered therapy in early arthritis patients in the IMPROVED study. Methods 610 patients with early rheumatoid or undifferentiated arthritis (RA or UA) started with methotrexate (MTX) 25mg/wk and prednisone 60mg/day tapered to 7.5mg/day...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2013-06, Vol.72 (Suppl 3), p.A401-A401
Hauptverfasser: Heimans, L., Wevers-de Boer, K. V., Visser, K., Goekoop-Ruiterman, Y. P., Molenaar, T. H., Harbers, J. B., Bijkerk, C., Speyer, I., de Buck, P. D., de Sonnaville, P. B., Grillet, B. A., Huizinga, T. W., Allaart, C. F.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To evaluate the 2 year clinical outcomes of remission steered therapy in early arthritis patients in the IMPROVED study. Methods 610 patients with early rheumatoid or undifferentiated arthritis (RA or UA) started with methotrexate (MTX) 25mg/wk and prednisone 60mg/day tapered to 7.5mg/day in 7 weeks. Patients who achieved a Disease Activity Score (DAS)
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2013-eular.1221